
Orgenesis, Inc. is a biotechnology company in the healthcare sector on NASDAQ. As of Q3 2025, 1 institutional investors hold shares in this company, with total holdings valued at $50.6K. Knoll Capital Management, LP is the largest holder with a position valued at $50.6K.
Overview of institutional ownership in ORGS as of Q3 2025
Institutions with the largest positions in ORGS as of Q3 2025
| Institution | Position Value |
|---|---|
K Knoll Capital Management, LP Institution | $50.6K 0.03% of portfolio |
Institutional buying and selling activity for ORGS in Q3 2025
| Institution | Net Bought | |
|---|---|---|
| No buyers found | ||
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Institutions that initiated new positions or completely exited ORGS in Q3 2025
| Institution | Position Value |
|---|---|
| No new positions found | |
| Institution | Previous Position |
|---|---|
| No exited positions found | |
Institutions with the largest Call and Put options positions in ORGS as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with ORGS as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
K Knoll Capital Management, LP Institution | 0.03% $50.6K |
We use cookies for analytics. See our Privacy and Cookie Policy.